-
TARGET SPECIES: Dogs.
INDICATIONS: The product is recommended in dogs for the treatment of dirofilariasis (Dirofilaria immitis), of the infestation with Toxocara canis, Toxascaris leonine, Ancylostoma caninum, Uncinaria stenocephala.
COMPOSITION:
1 tablet contains:
Active substance:
Pyrantel......................…………………………………..…… 114 mg
Ivermec......………………..…………………………...…….… 136 μg
Excipients q.s.ad ………………………….…………………1 tablet.
Excipients: lactose monohydrate, microcrystalline cellulose, stearic acid, identical natural chicken flavor, talc, magnesium stearate, colloidal silicon dioxideCONTRAINDICATIONS:
Do not administer in case of hypersensitivity to the active substances or to any of the excipients.
The product is indicated for dogs over 6 weeks of age.
Do not administer to dogs of the breeds Collie (and their half-breeds) and American Cocker.
ADVERSE REACTIONS:
Common ADVERSE REACTIONS in dogs are tremor, dilated pupils and body weight loss.
If you notice any adverse reaction, even those that are not included in this leaflet or if you believe that the medicine did not work, please inform your veterinarian.
ADMINISTRATION METHOD:
The product is administered orally in a dose of 1 tablet in animals with a body weight between 13 to 25 kg and 2 tablets in animals with a body weight between 26 to 50 kg. For the treatment of larval dirofilariasis (microfilariasis), the same dose is administered one month after the first administration, in order to prevent the development of the larvae.
RECOMMENDATIONS FOR PROPER ADMINISTRATION:
In order to ensure the correct dosage, the body weight must be determined as accurately as possible.
WITHDRAWAL PERIOD:
Not applicable.STORAGE:
Keep out of sight and reach of children.
Store at a temperature below 25ºC, in the original packaging.
Keep away from light and humidity.Cardboard boxes with 2 made of PVC/AL x 10 tablets each.